S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Pacira BioSciencesALX OncologyNektar TherapeuticsCytoDynGlobal Blood Therapeutics
SymbolNASDAQ:PCRXNASDAQ:ALXONASDAQ:NKTROTCMKTS:CYDYNASDAQ:GBT
Price Information
Current Price$72.56$87.68$23.62$4.52$44.48
52 Week RangeBuyBuyHoldHoldBuy
MarketRank™
Overall Score1.91.91.10.71.6
Analysis Score2.31.51.11.04.4
Community Score2.93.83.02.63.0
Dividend Score0.00.00.00.00.0
Ownership Score0.03.31.70.00.0
Earnings & Valuation Score4.40.60.00.00.6
Analyst Ratings
Consensus RecommendationBuyBuyHoldHoldBuy
Consensus Price Target$76.09$89.60$25.11$4.00$93.82
% Upside from Price Target4.87% upside2.19% upside6.31% upside-11.50% downside110.93% upside
Trade Information
Market Cap$3.15 billion$3.25 billion$4.24 billion$2.75 billion$2.75 billion
Beta1.27N/A1.76-0.641.39
Average Volume563,608193,0001,528,6854,277,1681,104,273
Sales & Book Value
Annual Revenue$421.03 millionN/A$114.62 millionN/A$2.11 million
Price / Sales7.49N/A36.97N/A1,302.69
Cashflow$1.70 per shareN/AN/AN/AN/A
Price / Cash42.56N/AN/AN/AN/A
Book Value$8.51 per shareN/A$7.99 per share($0.01) per share$9.61 per share
Price / Book8.53N/A2.96N/A4.63
Profitability
Net Income$-11,020,000.00N/A$-440,670,000.00$-124,400,000.00$-266,770,000.00
EPS$0.86N/A($2.52)($0.21)($4.71)
Trailing P/E Ratio25.550.00N/AN/AN/A
Forward P/E Ratio25.19N/AN/AN/A
P/E Growth0.82N/AN/AN/AN/A
Net Margins29.95%N/A-269.05%N/A-332.94%
Return on Equity (ROE)10.71%N/A-30.74%N/A-56.43%
Return on Assets (ROA)4.88%N/A-22.63%-153.30%-39.32%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.78%N/AN/A5.01%0.16%
Current Ratio7.63%N/A8.25%1.13%7.63%
Quick Ratio6.84%N/A8.15%0.28%7.20%
Ownership Information
Institutional Ownership PercentageN/A73.45%95.32%0.10%N/A
Insider Ownership Percentage5.80%N/A2.99%7.80%4.30%
Miscellaneous
Employees6061772319352
Shares Outstanding43.44 million37.11 million179.40 million608.41 million61.80 million
Next Earnings Date5/6/2021 (Estimated)3/4/2021 (Estimated)5/6/2021 (Estimated)4/8/2021 (Estimated)5/5/2021 (Estimated)
OptionableOptionableNot OptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.